Int J Sports Med 2015; 36(11): 867-871
DOI: 10.1055/s-0035-1550045
Physiology & Biochemistry
© Georg Thieme Verlag KG Stuttgart · New York

Effects of Running an Ultramarathon on Cardiac, Hematologic, and Metabolic Biomarkers

M. Khodaee
1   Family Medicine, University of Colorado Denver School of Medicine, Denver, United States
,
J. Spittler
1   Family Medicine, University of Colorado Denver School of Medicine, Denver, United States
,
K. VanBaak
1   Family Medicine, University of Colorado Denver School of Medicine, Denver, United States
,
B. G. Changstrom
2   Department of Family Medicine and Community Health, University of Minnesota School of Medicine, Minneapolis, United States
,
J. C. Hill
1   Family Medicine, University of Colorado Denver School of Medicine, Denver, United States
› Author Affiliations
Further Information

Publication History



accepted after revision 17 April 2015

Publication Date:
02 July 2015 (online)

Abstract

Serum biomarkers fluctuate as a result of running marathons, but their changes during ultramarathons have not been adequately studied. We collected blood samples from 20 participants before and 21 participants after the 161-km ultramarathon in Leadville, Colorado in August 2013. Using a portable analyzer, we measured cardiac troponin I (cTnl), hematologic, and metabolic biomarkers. Out of 10 runners for whom we collected both pre- and post-race samples, 8 were able to successfully complete the race. Mean cTnl increased from 0.001 to 0.047 ng/mL (p=0.005). Mean sodium decreased from 141 to 138 mmol/L (p <0.01). However, all runners had a sodium of ≥135 mmol/L post-race (reference range 138–146 mmol/L). Mean creatinine increased from 0.93 to 1.17 mg/dL (p <0.05). Only one out of 10 runners had an abnormal creatinine level of 1.8 mg/dL post-race (reference range 0.6–1.3 mg/dL). The other parameters did not reach statistical significance. Analyzing the samples from 21 runners after the race revealed that runners who finished the race in faster time had higher cTnl levels compared to those who finished the race close to the 30-hour cut-off finish time (P=0.005). Running an ultramarathon caused significant changes in cardiac and metabolic parameters. Ultramarathon running intensity and finish time may have effects on post-race cTnl level.

 
  • References

  • 1 Almond CS, Shin AY, Fortescue EB, Mannix RC, Wypij D, Binstadt BA, Duncan CN, Olson DP, Salerno AE, Newburger JW, Greenes DS. Hyponatremia among runners in the Boston Marathon. N Engl J Med 2005; 352: 1550-1556
  • 2 Baker P, Davies SL, Larkin J, Moult D, Benton S, Roberts A, Harris T. Changes to the cardiac biomarkers of non-elite athletes completing the 2009 London Marathon. Emerg Med J 2014; 31: 374-379
  • 3 Davila-Roman VG, Guest TM, Tuteur PG, Rowe WJ, Ladenson JH, Jaffe AS. Transient right but not left ventricular dysfunction after strenuous exercise at high altitude. J Am Coll Cardiol 1997; 30: 468-473
  • 4 Eijsvogels T, George K, Shave R, Gaze D, Levine BD, Hopman MT, Thijssen DH. Effect of prolonged walking on cardiac troponin levels. Am J Cardiol 2010; 105: 267-272
  • 5 Fallon KE, Sivyer G, Sivyer K, Dare A. Changes in haematological parameters and iron metabolism associated with a 1600 kilometre ultramarathon. Br J Sports Med 1999; 33: 27-31 discussion 32
  • 6 Harriss DJ, Atkinson G. Ethical standards in sport and exercise science research: 2014 update. Int J Sports Med 2013; 34: 1025-1028
  • 7 Hew-Butler T, Ayus JC, Kipps C, Maughan RJ, Mettler S, Meeuwisse WH, Page AJ, Reid SA, Rehrer NJ, Roberts WO, Rogers IR, Rosner MH, Siegel AJ, Speedy DB, Stuempfle KJ, Verbalis JG, Weschler LB, Wharam P. Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference, New Zealand, 2007. Clin J Sport Med 2008; 18: 111-121
  • 8 Hoffman MD, Hew-Butler T, Stuempfle KJ. Exercise-associated hyponatremia and hydration status in 161-km ultramarathoners. Med Sci Sports Exerc 2013; 45: 784-791
  • 9 Hoffman MD, Krishnan E. Exercise behavior of ultramarathon runners: baseline findings from the ULTRA study. J Strength Cond Res 2013; 27: 2939-2945
  • 10 Hoffman MD, Stuempfle KJ, Fogard K, Hew-Butler T, Winger J, Weiss RH. Urine dipstick analysis for identification of runners susceptible to acute kidney injury following an ultramarathon. J Sports Sci 2013; 31: 20-31
  • 11 Hoffman MD, Stuempfle KJ, Rogers IR, Weschler LB, Hew-Butler T. Hyponatremia in the 2009 161-km Western States Endurance Run. Int J Sports Physiol Perform 2012; 7: 6-10
  • 12 Jassal DS, Moffat D, Krahn J, Ahmadie R, Fang T, Eschun G, Sharma S. Cardiac injury markers in non-elite marathon runners. Int J Sports Med 2009; 30: 75-79
  • 13 Kao WF, Hou SK, Chiu YH, Chou SL, Kuo FC, Wang SH, Chen JJ. Effects of 100-km ultramarathon on acute kidney injury. Clin J Sport Med 2015; 25: 49-54
  • 14 Khodaee M, Ansari M. Common ultramarathon injuries and illnesses: race day management. Curr Sports Med Rep 2012; 11: 290-297
  • 15 Khodaee M, Myers R, Spittler J, Lee JA, Hill JC, Yeakel D. Risk factors for injuries in a high-altitude ultramarathon. Br J Sports Med 2011; 45: 355-356
  • 16 Kim YJ, Kim CH, Shin KA, Kim AC, Lee YH, Goh CW, Oh JK, Nam HS, Park Y. Cardiac markers of EIH athletes in ultramarathon. Int J Sports Med 2012; 33: 171-176
  • 17 Kim YJ, Shin YO, Lee JB, Lee YH, Shin KA, Kim AC, Goh CW, Kim C, Oh JK, Min YK, Yang HM. The effects of running a 308 km ultra-marathon on cardiac markers. Eur J Sport Sci 2014; 14 (Suppl. 01) S92-S97
  • 18 Knechtle B, Senn O, Imoberdorf R, Joleska I, Wirth A, Knechtle P, Rosemann T. No fluid overload in male ultra-runners during a 100 km ultra-run. Res Sports Med 2011; 19: 14-27
  • 19 Kratz A, Lewandrowski KB, Siegel AJ, Chun KY, Flood JG, Van Cott EM, Lee-Lewandrowski E. Effect of marathon running on hematologic and biochemical laboratory parameters, including cardiac markers. Am J Clin Pathol 2002; 118: 856-863
  • 20 Legaz-Arrese A, George K, Carranza-Garcia LE, Munguia-Izquierdo D, Moros-Garcia T, Serrano-Ostariz E. The impact of exercise intensity on the release of cardiac biomarkers in marathon runners. Eur J Appl Physiol 2011; 111: 2961-2967
  • 21 Lipman GS, Krabak BJ, Waite BL, Logan SB, Menon A, Chan GK. A prospective cohort study of acute kidney injury in multi-stage ultramarathon runners: the Biochemistry in Endurance Runner Study (BIERS). Res Sports Med 2014; 22: 185-192
  • 22 Mehta R, Gaze D, Mohan S, Williams KL, Sprung V, George K, Jeffries R, Hudson Z, Perry M, Shave R. Post-exercise cardiac troponin release is related to exercise training history. Int J Sports Med 2012; 33: 333-337
  • 23 Melanson SE, Green SM, Wood MJ, Neilan TG, Lewandrowski EL. Elevation of myeloperoxidase in conjunction with cardiac-specific markers after marathon running. Am J Clin Pathol 2006; 126: 888-893
  • 24 Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009; 55: 101-108
  • 25 Neumayr G, Pfister R, Hoertnagl H, Mitterbauer G, Prokop W, Joannidis M. Renal function and plasma volume following ultramarathon cycling. Int J Sports Med 2005; 26: 2-8
  • 26 Neumayr G, Pfister R, Mitterbauer G, Gaenzer H, Joannidis M, Eibl G, Hoertnagl H. Short-term effects of prolonged strenuous endurance exercise on the level of haematocrit in amateur cyclists. Int J Sports Med 2002; 23: 158-161
  • 27 Regwan S, Hulten EA, Martinho S, Slim J, Villines TC, Mitchell J, Slim AM. Marathon running as a cause of troponin elevation: a systematic review and meta-analysis. J Interv Cardiol 2010; 23: 443-450
  • 28 Salvagno GL, Schena F, Gelati M, Danese E, Cervellin G, Guidi GC, Lippi G. The concentration of high-sensitivity troponin I, galectin-3 and NT-proBNP substantially increase after a 60-km ultramarathon. Clin Chem Lab Med 2014; 52: 267-272
  • 29 Scotney B, Reid S. Body weight, serum sodium levels, and renal function in an ultra-distance mountain tun. Clin J Sport Med. 2014 Jul 9. [Epub ahead of print]
  • 30 Scott JM, Esch BT, Shave R, Warburton DE, Gaze D, George K. Cardiovascular consequences of completing a 160-km ultramarathon. Med Sci Sports Exerc 2009; 41: 26-34
  • 31 Serrano-Ostariz E, Terreros-Blanco JL, Legaz-Arrese A, George K, Shave R, Bocos-Terraz P, Izquierdo-Alvarez S, Bancalero JL, Echavarri JM, Quilez J, Aragones MT, Carranza-Garcia LE. The impact of exercise duration and intensity on the release of cardiac biomarkers. Scand J Med Sci Sports 2011; 21: 244-249
  • 32 Shave R, Baggish A, George K, Wood M, Scharhag J, Whyte G, Gaze D, Thompson PD. Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J Am Coll Cardiol 2010; 56: 169-176
  • 33 Shave R, George KP, Atkinson G, Hart E, Middleton N, Whyte G, Gaze D, Collinson PO. Exercise-induced cardiac troponin T release: a meta-analysis. Med Sci Sports Exerc 2007; 39: 2099-2106
  • 34 Shave RE, Dawson E, Whyte G, George K, Ball D, Gaze DC, Collinson PO. Evidence of exercise-induced cardiac dysfunction and elevated cTnT in separate cohorts competing in an ultra-endurance mountain marathon race. Int J Sports Med 2002; 23: 489-494
  • 35 Siegel AJ, Lewandrowski EL, Chun KY, Sholar MB, Fischman AJ, Lewandrowski KB. Changes in cardiac markers including B-natriuretic peptide in runners after the Boston marathon. Am J Cardiol 2001; 88: 920-923
  • 36 Wu HJ, Chen KT, Shee BW, Chang HC, Huang YJ, Yang RS. Effects of 24 h ultra-marathon on biochemical and hematological parameters. World J Gastroenterol 2004; 10: 2711-2714